Jiangsu Hengrui completes A-share buyback for employee stock ownership plan

Jiangsu Hengrui Medicine announced on November 20, 2025, the buyback of 209,940 A-shares, to be held as treasury shares for an employee stock ownership plan. The transaction, conducted on the Shanghai Stock Exchange, was executed at prices ranging from RMB 60.58 to RMB 60.78 per share, totaling an expenditure of RMB 12,743,212.8.

This buyback represents 0.0033% of the company's issued shares (excluding treasury shares) as of November 11, 2025. Following the buyback, the number of issued shares (excluding treasury shares) stands at 6,375,513,324, while the number of treasury shares increased to 3,488,950. The total number of issued shares remains unchanged at 6,379,002,274.

The company confirmed that all necessary regulatory approvals and legal requirements for this share repurchase were met, and the transaction was conducted in compliance with applicable rules of the Shanghai Stock Exchange.